Skip to main content
  • Methodology article
  • Open access
  • Published:

Visualization of C. elegans transgenic arrays by GFP

Abstract

Background

Targeting the green fluorescent protein (GFP) via the E. coli lac repressor (LacI) to a specific DNA sequence, the lac operator (lacO), allows visualization of chromosomes in yeast and mammalian cells. In principle this method of visualization could be used for genetic mosaic analysis, which requires cell-autonomous markers that can be scored easily and at single cell resolution. The C. elegans lin-3 gene encodes an epidermal growth factor family (EGF) growth factor. lin-3 is expressed in the gonadal anchor cell and acts through LET-23 (transmembrane protein tyrosine kinase and ortholog of EGF receptor) to signal the vulval precursor cells to generate vulval tissue. lin-3 is expressed in the vulval cells later, and recent evidence raises the possibility that lin-3 acts in the vulval cells as a relay signal during vulval induction. It is thus of interest to test the site of action of lin-3 by mosaic analysis.

Results

We visualized transgenes in living C. elegans by targeting the green fluorescent protein (GFP) via the E. coli lac repressor (LacI) to a specific 256 sequence repeat of the lac operator (lacO) incorporated into transgenes. We engineered animals to express a nuclear-localized GFP-LacI fusion protein. C. elegans cells having a lacO transgene result in nuclear-localized bright spots (i.e., GFP-LacI bound to lacO). Cells with diffuse nuclear fluorescence correspond to unbound nuclear localized GFP-LacI. We detected chromosomes in living animals by chromosomally integrating the array of the lacO repeat sequence and visualizing the integrated transgene with GFP-LacI.

This detection system can be applied to determine polyploidy as well as investigating chromosome segregation. To assess the GFP-LacI•lacO system as a marker for mosaic analysis, we conducted genetic mosaic analysis of the epidermal growth factor lin-3, expressed in the anchor cell. We establish that lin-3 acts in the anchor cell to induce vulva development, demonstrating this method's utility in detecting the presence of a transgene.

Conclusion

The GFP-LacI•lacO transgene detection system works in C. elegans for visualization of chromosomes and extrachromosomal transgenes. It can be used as a marker for genetic mosaic analysis. The lacO repeat sequence as an extrachromosomal array becomes a valuable technique allowing rapid, accurate determination of spontaneous loss of the array, thereby allowing high-resolution mosaic analysis. The lin-3 gene is required in the anchor cell to induce the epidermal vulval precursors cells to undergo vulval development.

Background

The green fluorescent protein (GFP) of the jellyfish Aequorea victoria has been used extensively for observation in vivo of gene expression and cell morphology in C. elegans [1–4]. GFP has also been targeted to specific subcellular structures by fusing GFP to various proteins. A technique utilizing a chimeric protein of GFP (S65T) and the E. coli lac repressor (LacI) along with lac operator (lacO) makes the visualization of chromosomes possible [5–8]. This fusion protein has the DNA-binding capability of LacI and the fluorescent properties of GFP. The fusion protein is capable of binding to the lacO, thus localizing GFP expression at the DNA repeat. Such localization allows direct visualization of segregating chromosomes during mitosis.

We have applied the GFP-LacI technique to C. elegans. We show that the GFP-LacI•lacO repeat technique allows visualization of transgenes present as either extrachromosomal arrays or integrated into a chromosome. The integrated version allows visualization of chromosomal segregation and determination of polyploidy.

Visualization of extrachromosomal arrays provides a method to detect transgenes used for mosaic analysis. Genetic mosaics in C. elegans are typically generated by the spontaneous somatic loss of an extrachromosomal transgenic array or a free duplication [9–13]. When the free duplication or extrachromosomal array containing a wild-type cell-autonomous marker gene (often ncl-1; enlarged nucleoli) and a gene of interest is lost from one of the daughter cells during mitosis, it gives rise to a lineage of cells lacking wild-type activity of the marker gene and of the gene of interest. Extra-chromosomal arrays are mitotically unstable, resulting in a complex mosaic pattern, establishing a method of scoring individual cells under Nomarski differential interference contrast microscopy.

The inductive signal for hermaphrodite vulval differentiation is the epidermal growth factor (EGF) like protein LIN-3 [14, 15]. lin-3 encodes proteins that have an extracellular domain with one EGF motif, a transmembrane domain and a cytoplasmic domain. In the presence of the gonadal anchor cell (AC), three of the six vulva precursor cells (VPCs) undergo three rounds of mitosis and generate the cells that form the vulva. The VPCs are the posterior daughters (P3.p-P8.p) of six of the twelve Pn cells present at hatching [16, 17]. The VPC (P6.p) nearest to the AC will adopt the 1° fate since it receives more signal than its neighbors. P5.p and P7.p cells are induced to adopt the 2° fate, either directly by LIN-3 [18] or indirectly via the 1° VPC [19]. The VPCs (P3.p, P4.p. and P8.p) further from the AC adopt the 3° fate, which is to generate two non-vulval descendants that fuse with the hyp7 epidermal syncytium. The fates adopted by the VPCs are distinguished in part by the number of progeny they generate. The 1° and 2° cell fates generate eight and seven descendants, respectively, which form the mature vulva [15]. Decreased lin-3 activity results in decreased vulval development while overexpression of lin-3 results in increased vulval development. Genetic epistasis tests indicated that lin-3 acts upstream of let-23, sem-5, let-341, let-60, lin-45, mek-2 and mpk-1 during vulval induction [reviewed by [20]]. Based upon lacZ and GFP reporter gene constructs, lin-3 is expressed in the anchor cell at the time of vulval induction [14, 21–23], and in the 1° vulval lineage after vulval induction [24]. Recently, Dutt et al. [25] argue based on molecular genetic experiments that lin-3 can act in the VPCs to extend the range of induction. Based upon its structure, expression and genetic properties, the AC has been proposed to secrete LIN-3 protein [14, 18]. We have tested by mosaic analysis, using GFP-LacI•lacO, whether lin-3 signal is required solely in the anchor cell for vulval induction.

Results and discussion

Visualization of chromosomes

To test whether the GFP-LacI•lacO system could be used to visualize the DNA of extrachromosomal arrays in C. elegans, we engineered sequences that encode a GFP-LacI fusion protein under the control of the heat-shock enhancer/promoter in vector pPD49-78 (hsGFP-LacI). We then microinjected a DNA mixture containing hsGFP-LacI, the lacO repeat and dpy-20 rescuing DNA (pMH86) into the gonad of an adult dpy-20(e1282) hermaphrodite. After a 30-minute heat-shock at 33°C, transformants were found to express nuclear GFP and have intense foci of subnuclear fluorescence, presumably corresponding to the DNA of the extrachromosomal arrays. DAPI co-staining confirmed that the GFP-LacI•lacO system has nuclear expression and association with DNA. We first detected expression in embryos at early gastrulation (~24 cell stage). Larvae and adults express GFP broadly.

DNA molecules injected into the C. elegans gonad syncytium assemble into arrays; extrachromosomal arrays consist of many rearrangements of the DNA injected [26]. The fusion protein bound to the lacO repeat resulting in one to two bright spots per nucleus as well as the unbound fusion protein resulting in nuclear diffuse fluorescence ("haze") (Figure 1). Mitotic loss of these mixed extrachromosomal arrays in a single founder cell results in a clone of cells lacking the activities of all genes in the array [11, 27].

Figure 1
figure 1

Visualization of C. elegans extrachromosomal arrays by GFP. One to two bright spots are seen per nucleus when the fusion proteins are bound to the lacO array. If the fusion proteins remain unbound, then the nucleus has diffuse fluorescence (arrowheads). If fusion proteins bind to the lacO array then the nucleus have localized bright spots (arrows). (A) Embryos: dpy-20; syEx [pMH86, pPD49-78::GFP-LacI, lacO] embryos were mounted on 5% Noble agar and examined under Nomarski optics and epifluorescence at 100 X. (B) A confocal photomicrograph of a syIs44 L4 hermaphrodite pharynx.

To test the reliability and consistency of the GFP-LacI•lacO as a detection method for transgenes, we examined animals in which every cell has the lacO array and in which most cells express GFP-LacI. Specifically, non-Dpy transformants of dpy-20(e1282); syEx [pMH86 + pPD49-78GFP-LacI + lacO] were X-irradiated to integrate the transgenic array into the genome, yielding integrated transgene syIs44 in the strain PS2442 (Table 1). In this strain, we observed that most nuclei had one or more spots of fluorescence (see Figure 1B). Detection of chromosomes was efficient. For example, we observed two pairs of sister cells in each of the 20 animals, the embryonic sisters F and U and the postembryonic sisters P8.pa and P8.pp. We found that all 80 cells had one or two fluorescent spots. Therefore, we are able to detect a transgene in every cell.

Table 1 Transgenes and strains

We then examined the behavior of an extrachromosomal transgene carrying lacO in a strain (PS3427) that expressed GFP-LacI from an integrated trasngene (syIs46). To ascertain whether the loss of the array coincides with the progenitor cell and its two daughters, we looked at the nuclei of two sister cells, namely, F and U (Table 2). Of the 67 animals viewed with the integrated GFP-LacI and the extrachromosomal lacO, 65.6% of the progenitor cells had a localized bright spot (i.e., array present). Of the 65.6% progenitor cells having a localized bright spot, 15.9% pass the array to only one of the daughter cells.

Table 2 Apparent loss rate per cell division: FU sister cells. -/- : cell had lost the array; +/- : loss at this cell division; +/+: no loss at this cell division. Loss rate is [+/-]/[(+/+) +(+/-)]. Strain PS3427 (Table 1), integrated GFP-LacI. n = 67 animals.

GFP-LacI • lacO as a single cell marker

The ncl-1(e1865) mutation results in enlarged nucleoli of a large number of cell types (the Ncl phenotype). Since ncl-1 acts in a cell autonomous manner, it is useful as a cell lineage marker [10]. The cosmid clone (C33C3) rescues the ncl-1 phenotype and has been used as a cell lineage marker on extrachromosomal arrays [28–30]. To test the utility of the GFP-LacI•lacO technique as a single cell marker, we compared it with ncl-1. A DNA mixture composed of the lacO repeat, C33C3, and lin-15B (+) DNA was injected into the gonads of syIs46; ncl-1(e1865); dpy-20 (e1282); lin-15(e1763) animals. The isolated transgenic mosaic animals were then heat shocked (See Methods). We scored the Ncl phenotype in the nucleoli of 22 different cells (m2, m3L, m3VL, m4, m3R, m3VR, m3DR, m3DL, hyp7 dorsal head, hyp7 ventral head, P/I, p3.p, P4.p, P5.p, P6, p, P7.p, P8.p, B, F, U, hyp7 ventral tail, hyp7 anus) per mosaic animal (n = 37; Table 3). The presence of the spot is unequivocal evidence that the transgene is present. The existence of Ncl cells with fluorescent spots thus clearly indicates a false negative by Ncl-1. Conversely, non-Ncl cells without a fluorescent spot suggests either the perdurance of the NCL-1 protein (i.e., false positive) or a false negative by GFP-LacI•lacO. Both markers agree in scoring approximately 80%, while false negatives of Ncl-1 (N, +) occur about 16% (Table 3). The occurrence of false positives of Ncl-1 (W, -) is 2%. However, neither marker is perfect. The Ncl marker is undetectable in intestinal nucleoli and endogenously large nucleoli such as some hyp cells and muscle cells. The GFP-LacI•lacO system has a higher apparent loss rate per cell division (15.9%; Table 3; discussed later) as well as bleaching of GFP.

Table 3 ncl-1 versus GFP-LacI•lacO as markers for mosaic analysis.

One explanation for the lack of intense fluorescent spots (false negatives by GFP-LacI•lacO) is that the expression of GFP-LacI is insufficient. We thought this possibility likely since the expression initially depended on the GFP filter combination used, and the light source (200 watt vs. 100 watt HBO burner). To increase the sensitivity, we engineered a GFP-LacI under the control of the ubiquitously expressed dpy-30 enhancer/promoter [31]. Another possibility is that non-Ncl nuclei without spots reflect perdurance of NCL-1.

The combined use of the cell lineage marker ncl-1 and the GFP-LacI•lacO would increase the accuracy and ease of mosaic analysis. In order to use both markers, the double mutant ncl-1; dpy-20 was injected with the DNA mixture (pMH86 (dpy-20(+) + pPD49-78::GFP-LacI + dpy-30::GFP-LacI). Once non-Dpy transformants were isolated, the extrachromosomal array was integrated into the genome by X-ray irradiation to yield strain PS2958 syIs46 [pMH86 + pPD49-78::GFP-LacI + dpy-30:: S65T*LacI] II; ncl-1 III; dpy-20 IV. This strain became the basis for our genetic mosaic analysis of lin-3, discussed below.

The comparison between ncl-1 and the GFP-LacI•lacO as single cell markers indicate that GFP-LacI•lacO is comparable in its reliability to ncl-1 as a cell lineage marker for the presence of a transgene (Table 3). The main advantage of using the fusion protein GFP-LacI•lacO rather than Ncl is that scoring the mutant Ncl phenotype is typically more difficult than scoring cells with the bound GFP-LacI fusion protein. Also, GFP-LacI can be used in cells such as intestinal cells for which ncl-1 is not applicable. We find that the GFP-LacI method (spot or not spot) is much easier than scoring nucleolus size. Such ease of scoring may also be used for more accurate mosaic analysis. The comparison between the GFP-LacI•lacO and ncl-1 as a single cell marker as well as its loss rate per cell division (Tables 2 and 3) confirms that using both the Ncl-1 phenotype and the integrated GFP-LacI together will increase the accuracy of mosaic analysis. An alternative mosaic marker, the nuclear-localized SUR-5-GFP, demonstrates the ease and speed of scoring cells by fluorescence comparative to the ncl-1 marker [30]. This technique allows to rapidly screen with a dissecting microscope for rare mosaic animals, unlike the GFP-LacI•lacO methodology that requires a compound microscope. SUR-5-GFP is an excellent mosaic marker for determining if the gene of interest is either in the AB or P1 lineage but for finer single cell analysis, either ncl-1 or GFP-LacI•lacO is required. Another limitation of SUR-5-GFP is its limited expression pattern. GFP-LacI•lacO is expressed throughout the somatic cell lineage.

The high apparent loss rate of GFP-LacI•lacO, for example 15.9% per cell division in one experiment, could result from two general causes. First, the presence of lacO repeats might lead to decreased stability of the arrays. Second, the presence of the repeats might increase silencing of the transgenes in some manner [32]. We also believe that the ability to detect rapidly the presence of the transgene in individual cells affords a more accurate picture of the degree of mosaicism than gross phenotypic description.

Polyploidy

Our method for ploidy detection was tested by injecting a DNA mixture consisting of a fusion protein under the control of the heat-shock promoter pPD49-78, the lacO repeat, plus rol-6(su1006) dominant into a lin-5(e1348) mutant, which fails to undergo mitosis [33]. The Rol segregants of strain PS2629 confirmed that GFP-LacI +lacO could detect polyploid cells. Multiple dots have been seen when viewing known polyploid cells (i.e., intestines and hypodermal cells; Figure 2). We conclude that the GFP-LacI•lacO method is useful in determining which cells are polyploid. However, the number of spots within the cell cannot unambiguously determine the extent of ploidy. In particular, diploid cells have 1–3 spots while polyploid cells have ≥ 4 spots.

Figure 2
figure 2

Assay for polyploidy of nuclei. Comparison of body muscle between syIs44 [dpy-20(+)+pPD49-78::GFPlacI+lacO]; dpy-20 and lin-5(e1348), dpy-10(e128) II; syEx207 [pRF4 (rol-6(su1006)) +pPD49-78GFP-LacI+lacO]. Animals were mounted on 5% Noble agar containing ~100 nM levamisole and examined under Nomarski microscopy and fluorescence at 100X. a) lin-5(e1348), dpy-10(e128) II; syEx207 L4 hermaphrodite. b)syIs44; dpy-20 L4 hermaphrodite. Arrows point to GFP-LacI bound to lacO.

The number of fluorescent spots per nucleus does not correlate precisely with the expected copy number, raising the possibility that there is some synapsis of chromosomes at some stages of the cell cycle. Nonetheless, while examination of a single cell is not sufficient, examination of several cells would be, and thus this method could be used for screens or as an assay for alterations in ploidy.

GFP-LacI•lacO as a mosaic marker

As a test of this method of mosaic analysis, we chose to determine the site of action of lin-3 for its role in vulval induction. lin-3 was proposed to act in the anchor cell based upon its expression in the anchor cell, and its expression under control of heat shock enhancer/promoter could compensate for lack of an anchor cell[14, 21–23]. We used a strain heterozygous for two mutant alleles of lin-3: n378, which is defective only in vulval development and n1059 (a genetically-defined null allele) in order to decrease lin-3 activity in vulval induction but still have viable animals [14, 34, 35]. A strain of genotype syIs46; lin-3(n378) let-59(s49) unc-22(s7)/lin-3(n1059) unc-24(e138) was injected with lin-3(+) (20 ng/μl), lacO (50 ng/μl), transformation marker pPD118-33 (myo-2::GFP) (16 ng/μl)[36], and carrier DNA BSK+II (120 ng/μl).

We examined animals with a fluorescent pharynx due to expression of MYO-2::GFP. These animals have the transgene in either the AB lineage or P1 lineage or both [36]. We picked L3–L4 animals expressing myo-2::GFP by viewing them under a dissecting microscope with a GFP filter. These animals were then heat-shocked for 30 minutes in a 33°C water-bath followed by a one-hour recovery period in a 20°C incubator.

We examined a total of 114 animals prescreened under a dissecting stereomicroscope. We considered three possibilities: lin-3 acts in the AC, it acts in the VPCs or both since lacZ and GFP reporter gene constructs indicate lin-3 expression in the anchor cell at the time of vulval induction [14, 21–23], and that it acts in the 1° vulval lineage after vulval induction [24, 25]. We scored the AC and the VPCs of wild type, Vul and Muv lin-3 transgenic animals. Of the 114 animals, 91 had wild-type vulva, 15 animals were vulvaless and eight animals were multivulva. Eighty-eight animals with the array present in both the AC and VPCs were wild type or Muv. All eight animals lacking the array in both the AC and VPCs were Vul, indicating that lin-3 is necessary either in the anchor cell, the VPCs or both. Of nine animals that had the array in the AC but not in the VPCs, eight were wild type and one was Muv (Table 4, Figure 3A–D), indicating that expression of lin-3 in the anchor cell is sufficient for vulval induction. All seven animals that had the array in the VPCs but not in the AC were Vul (Table 4 and Figure 3E–F), indicating that expression of lin-3 in the VPCs is not sufficient to induce the vulva. We conclude that lin-3 acts in the AC during vulval induction. Seven of sixteen animals (W.26, W.58, W.64, W.84, V.2, V.7 and V.10) had late losses during Pn.px divisions resulting in a complex mosaic pattern. We conclude that a subset of cells involved in vulva formation having the lin-3 gene can neither induce nor hinder vulval induction.

Figure 3
figure 3

lin-3 mosaic analyis. (A) lin-3 mosaic animal at L4 stage with normal vulval development. Anchor cell labeled with arrowhead; bar indicates vulva. (B) Same lin-3 mosaic animal viewed under epifluoresence. The anchor cell has an intense spot of fluorescence, and thus the transgenic array (lin-3(+) + lacO + pPD118-33). The vulval descendants do not have the intense spot of fluorescence, and thus lack the transgenic array. (C) lin-3 mosaic animal at L4 stage with no Pn.px cells adopting vulval fate. Anchor cell labeled with arrowhead. Pn.px cell progeny labeled with arrows. (D) Same lin-3 mosaic animal viewed under epifluoresence. The anchor cell does not have the intense spot of fluorescence, and thus lacks the transgenic array (lin-3(+) + lacO + pPD118-33). The Pn.px cells do have the intense spot of fluorescence, and thus have the transgenic array. (E) lin-3 mosaic animal at L4 stage with multivulva phenotype. Anchor cell labeled with arrowhead; bar indicates vulva. (F) Same lin-3 mosaic animal viewed under epifluoresence. The anchor cell has an intense spot of fluorescence, and thus the transgenic array. The vulval descendants do not have the intense spot of fluorescence, and thus lack the transgenic array.

Table 4 Mosaic analysis of lin-3 with GFP-LacI•lacO

Conclusion

We demonstrated that GFP-LacI•lacO can be used to visualize transgenes in living C. elegans, either as extrachromosomal arrays or as arrays integrated into a chromosome. We also showed GFP-LacI•lacO as a useful marker for ploidy determination in vivo. In addition, we showed that this direct visualization using transgenes facilitate the high-resolution of mosaic analysis. The ease and accuracy of detecting mosaics using GFP-LacI•lacO were examined by comparing its efficiency with ncl-1 as a single cell marker. We demonstrated the utility of GFP-LacI•lacO as a mosaic marker by demonstrating that the lin-3 site of action for vulval induction is in the anchor cell. Overall, GFP-LacI•lacO is a useful tool for several aspects of C. elegans molecular genetics. Indeed, our system have been successfully used in several experiments by others to co-localize proteins binding DNA and for determination of ploidy [37–43].

Methods

Nematode methods

Growth and handling of C. elegans strain N2 were according to Brenner [44]. All experiments were performed at about 20°C unless otherwise stated. The genetic and cellular nomenclature of C. elegans was followed according to [45] and [17], respectively.

Strains

The standard wild-type N2 strains and other mutant strains used (ncl-1(e1865) and lin-5(e1348) dpy-10(e128) II) was obtained from the Caenorhabditis Genetics Center (USA).

The transgene syEx [(dpy-20(+) (20 ng/μl) + pPD49-78 GFP-LacI (100 ng/ml) + lacO (50 ng/μl)] was integrated into a dpy-20(e1282)IV strain via X-ray irradiation [46]to yield PS2442 with syIs44 (Table 1). The transgene syEx [dpy-20(+) (20 ng/μl) +dpy-30::S65T*LacI (100 ng/μl) + pPD49-78 GFP-LacI (100 ng/μl)] was integrated into a ncl-1; dpy-20(e1282)IV strain via X-ray irradiation [46] to yield PS2958 with syIs46 (Table 1).

GFP-LacI fusion and 256 lacO repeat

The GFP-LacI fusion protein and the lacO repeat [6–8] were graciously given to us by Andrew Belmont. We placed GFP-LacI under the transcriptional control of an hsp16 promoter/enhancer element pPD49-78 [47, 48] The fusion protein was inserted into KpnI/SacI site of heat shock vector pPD49-78. pPD49-78 is expressed very well in the neural and hypodermal cells, as well as in the gut, muscles, and pharynx but not in the germline [47, 48]. The GFP-LacI coding sequences were also placed under the transcriptional control of the dpy-30 promoter graciously provided by Barbara Meyer. The dpy-30 promoter/enhancer directs expression throughout the animal's somatic cells. [31]. The GFP was replaced with GFP(S65T) from the vector pPD93-65, which contains introns, in order to increase translation of the fusion protein [47]. The GFP (now designated S65T*) is inserted in the KpnI/EcoRI site of the dpy-30::GFP-LacI plasmid, now called dpy-30::S65T*-LacI.

Germline-mediated transformation by microinjection

Microinjection was performed according to Mello et al. ([26]). Young adult hermaphrodites were placed live on pads of 2% agarose under an inverted differential contrast-interference (Nomarski) microscope (Carl Zeiss, Oberkochen, West Germany) and the DNA was injected into the gonad using an Eppendorf micro injector 5242 (Eppendorf Gertebau Netheler, Hamburg, West Germany). The Ncl vs. GFP-LacI experiments was done in a syIs46; lin-15(e1763) background. The injection mixture for the Ncl vs. GFP-LacI experiment contained the 256 repeat lacO array (50 ng/μl), cosmid C33C3 (rescues the Ncl-1 mutant phenotype [29, 49] (50 ng/μl), lin-15B(+) genomic DNA (50 ng/μl) and pBluescript II SK+ (Stratagene) as carrier DNA (5 ng/μl). For the polyploidy experiments, the plasmid pRF4, containing the rol-6(su1006) mutant gene [26], was used as a dominant transformation marker at a concentration of 40 ng/μl. The injection mixture for the polyploidy experiments contained pPD49-78::GFP-LacI (100 ng/μl), 256 repeat lacO array (50 ng/μl), and pBluescript II SK+ (Stratagene) as carrier DNA (5 ng/μl). This injection mixture was injected into the gonads of lin-5(e1348) dpy-10(e128) II to yield syEx207 in the strain PS2629.

The transgenic lines obtained from each experiment were heat-shocked for 30 minutes at 33°C to elicit GFP-LacI expression. Expression of the GFP-LacI can be seen as early as 30 minutes after heat-shock, and as late as 24 hours.

Mosaic analysis of lin-3 gene function in vulval induction

Mosaic animals were obtained from a somatic loss of the extrachromosomal array syEx345 [lin-3(+), lacO, myo-2::GFP(pPD118-33)] from the vulvaless strain PS3427 syIs46; lin-3(n378) let-59(s49) unc22(s7)/lin-3(n1059)unc-24(e138) (Table 1). The point of loss was determined by the absence of fluorescent spots in cells of interest. For mosaic analysis, we used L3–L4 wild-type, multivulva, and vulvaless animals with their pharynges fluorescing due to expression of MYO-2::GFP [36] to ensure the array was present in the zygote. The nuclei observed to identify mosaic animals were: AC, P3.p, P4.p, P5.p, P6.p, P7.p and P8.p, or the descendants of these latter six cells.

Microscopy and photography

Animals were anesthetized with 2 mM levamisole on 5% Noble agar pads. Photographs were taken on Kodak Ektachrome, ASA 160 or Fuji Provia, ASA 400 on a Zeiss Axioplan with Chroma High Q GFP LP filter set (absorption band 450 nm and 505 nm emission) at 100 X optics or by confocal photomicrography for strain PS2442.

Abbreviations

Is:

Insertion Site (integrated transgene)

GFP:

green fluorescent protein

References

  1. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC: Green fluorescent protein as a marker for gene expression. Science. 1994, 263 (5148): 802-805.

    Article  PubMed  CAS  Google Scholar 

  2. Cubitt AB, Heim R, Adams SR, Boyd AE, Gross LA, Tsien RY: Understanding, improving and using green fluorescent proteins. Trends Biochem Sci. 1995, 20 (11): 448-455. 10.1016/S0968-0004(00)89099-4.

    Article  PubMed  CAS  Google Scholar 

  3. Heim R, Prasher DC, Tsien RY: Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc Natl Acad Sci U S A. 1994, 91 (26): 12501-12504. 10.1073/pnas.91.26.12501.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  4. Heim R, Tsien RY: Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr Biol. 1996, 6 (2): 178-182. 10.1016/S0960-9822(02)00450-5.

    Article  PubMed  CAS  Google Scholar 

  5. Belmont AS, Straight AF: In vivo visualization of chromosomes using lac operator-repressor binding. Trends Cell Biol. 1998, 8 (3): 121-124. 10.1016/S0962-8924(97)01211-7.

    Article  PubMed  CAS  Google Scholar 

  6. Robinett CC, Straight A, Li G, Willhelm C, Sudlow G, Murray A, Belmont AS: In vivo localization of DNA sequences and visualization of large-scale chromatin organization using lac operator/repressor recognition. J Cell Biol. 1996, 135 (6 Pt 2): 1685-1700. 10.1083/jcb.135.6.1685.

    Article  PubMed  CAS  Google Scholar 

  7. Straight AF, Belmont AS, Robinett CC, Murray AW: GFP tagging of budding yeast chromosomes reveals that protein-protein interactions can mediate sister chromatid cohesion. Curr Biol. 1996, 6 (12): 1599-1608. 10.1016/S0960-9822(02)70783-5.

    Article  PubMed  CAS  Google Scholar 

  8. Webb CD, Decatur A, Teleman A, Losick R: Use of green fluorescent protein for visualization of cell-specific gene expression and subcellular protein localization during sporulation in Bacillus subtilis. J Bacteriol. 1995, 177 (20): 5906-5911.

    PubMed  CAS  PubMed Central  Google Scholar 

  9. Yochem J, Herman RK: Genetic Mosaics. WormBook. Edited by: Community TCR. 2005, http://www.wormbook.org

    Google Scholar 

  10. Hedgecock EM, Herman RK: The ncl-1 gene and genetic mosaics of Caenorhabditis elegans. Genetics. 1995, 141 (3): 989-1006.

    PubMed  CAS  PubMed Central  Google Scholar 

  11. Herman RK: Analysis of genetic mosaics of the nematode Caneorhabditis elegans. Genetics. 1984, 108 (1): 165-180.

    PubMed  CAS  PubMed Central  Google Scholar 

  12. Herman RK, Hedgecock EM: Limitation of the size of the vulval primordium of Caenorhabditis elegans by lin-15 expression in surrounding hypodermis. Nature. 1990, 348 (6297): 169-171. 10.1038/348169a0.

    Article  PubMed  CAS  Google Scholar 

  13. Miller LM, Gallegos ME, Morisseau BA, Kim SK: lin-31, a Caenorhabditis elegans HNF-3/fork head transcription factor homolog, specifies three alternative cell fates in vulval development. Genes Dev. 1993, 7 (6): 933-947.

    Article  PubMed  CAS  Google Scholar 

  14. Hill RJ, Sternberg PW: The gene lin-3 encodes an inductive signal for vulval development in C. elegans. Nature. 1992, 358 (6386): 470-476. 10.1038/358470a0.

    Article  PubMed  CAS  Google Scholar 

  15. Sternberg PW: Vulval development. WormBook,. Edited by: Community TCR. 2005, http://www.wormbook.org

    Google Scholar 

  16. Sternberg PW, Horvitz HR: Pattern formation during vulval development in C. elegans. Cell. 1986, 44 (5): 761-772. 10.1016/0092-8674(86)90842-1.

    Article  PubMed  CAS  Google Scholar 

  17. Sulston JE, Horvitz HR: Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol. 1977, 56 (1): 110-156. 10.1016/0012-1606(77)90158-0.

    Article  PubMed  CAS  Google Scholar 

  18. Katz WS, Hill RJ, Clandinin TR, Sternberg PW: Different levels of the C. elegans growth factor LIN-3 promote distinct vulval precursor fates. Cell. 1995, 82 (2): 297-307. 10.1016/0092-8674(95)90317-8.

    Article  PubMed  CAS  Google Scholar 

  19. Simske JS, Kim SK: Sequential signalling during Caenorhabditis elegans vulval induction. Nature. 1995, 375 (6527): 142-146. 10.1038/375142a0.

    Article  PubMed  CAS  Google Scholar 

  20. Sundaram MV: RTK/Ras/MAPK signaling. WormBook. 2005, http://www.wormbook.org

    Google Scholar 

  21. Kimble J: Alterations in cell lineage following laser ablation of cells in the somatic gonad of Caenorhabditis elegans. Dev Biol. 1981, 87 (2): 286-300. 10.1016/0012-1606(81)90152-4.

    Article  PubMed  CAS  Google Scholar 

  22. Wang M, Sternberg PW: Competence and commitment of Caenorhabditis elegans vulval precursor cells. Dev Biol. 1999, 212 (1): 12-24. 10.1006/dbio.1999.9357.

    Article  PubMed  CAS  Google Scholar 

  23. Hwang BJ, Sternberg PW: A cell-specific enhancer that specifies lin-3 expression in the C. elegans anchor cell for vulval development. Development. 2004, 131 (1): 143-151. 10.1242/dev.00924.

    Article  PubMed  CAS  Google Scholar 

  24. Chang C, Newman AP, Sternberg PW: Reciprocal EGF signaling back to the uterus from the induced C. elegans vulva coordinates morphogenesis of epithelia. Curr Biol. 1999, 9 (5): 237-246. 10.1016/S0960-9822(99)80112-2.

    Article  PubMed  CAS  Google Scholar 

  25. Dutt A, Canevascini S, Froehli-Hoier E, Hajnal A: EGF signal propagation during C. elegans vulval development mediated by ROM-1 rhomboid. PLoS Biol. 2004, 2 (11): e334-10.1371/journal.pbio.0020334.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Mello CC, Kramer JM, Stinchcomb D, Ambros V: Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. Embo J. 1991, 10 (12): 3959-3970.

    PubMed  CAS  PubMed Central  Google Scholar 

  27. Yochem J, Hall DH, Bell LR, Hedgecock EM, Herman RK: Isopentenyl-diphosphate isomerase is essential for viability of Caenorhabditis elegans. Mol Genet Genomics. 2005, 273 (2): 158-166. 10.1007/s00438-004-1101-x.

    Article  PubMed  CAS  Google Scholar 

  28. Koga M, Ohshima Y: Mosaic analysis of the let-23 gene function in vulval induction of Caenorhabditis elegans. Development. 1995, 121 (8): 2655-2666.

    PubMed  CAS  Google Scholar 

  29. Miller LM, Waring DA, Kim SK: Mosaic analysis using a ncl-1 (+) extrachromosomal array reveals that lin-31 acts in the Pn.p cells during Caenorhabditis elegans vulval development. Genetics. 1996, 143 (3): 1181-1191.

    PubMed  CAS  PubMed Central  Google Scholar 

  30. Yochem J, Gu T, Han M: A new marker for mosaic analysis in Caenorhabditis elegans indicates a fusion between hyp6 and hyp7, two major components of the hypodermis. Genetics. 1998, 149 (3): 1323-1334.

    PubMed  CAS  PubMed Central  Google Scholar 

  31. Hsu DR, Chuang PT, Meyer BJ: DPY-30, a nuclear protein essential early in embryogenesis for Caenorhabditis elegans dosage compensation. Development. 1995, 121 (10): 3323-3334.

    PubMed  CAS  Google Scholar 

  32. Kelly WG, Xu S, Montgomery MK, Fire A: Distinct requirements for somatic and germline expression of a generally expressed Caernorhabditis elegans gene. Genetics. 1997, 146 (1): 227-238.

    PubMed  CAS  PubMed Central  Google Scholar 

  33. Albertson DG, Sulston JE, White JG: Cell cycling and DNA replication in a mutant blocked in cell division in the nematode Caenorhabditis elegans. Dev Biol. 1978, 63 (1): 165-178. 10.1016/0012-1606(78)90122-7.

    Article  PubMed  CAS  Google Scholar 

  34. Ferguson EL, Horvitz HR: Identification and characterization of 22 genes that affect the vulval cell lineages of the nematode Caenorhabditis elegans. Genetics. 1985, 110 (1): 17-72.

    PubMed  CAS  PubMed Central  Google Scholar 

  35. Liu J, Tzou P, Hill RJ, Sternberg PW: Structural requirements for the tissue-specific and tissue-general functions of the Caenorhabditis elegans epidermal growth factor LIN-3. Genetics. 1999, 153 (3): 1257-1269.

    PubMed  CAS  PubMed Central  Google Scholar 

  36. Okkema PG, Harrison SW, Plunger V, Aryana A, Fire A: Sequence requirements for myosin gene expression and regulation in Caenorhabditis elegans. Genetics. 1993, 135 (2): 385-404.

    PubMed  CAS  PubMed Central  Google Scholar 

  37. Carmi I, Kopczynski JB, Meyer BJ: The nuclear hormone receptor SEX-1 is an X-chromosome signal that determines nematode sex. Nature. 1998, 396 (6707): 168-173. 10.1038/24164.

    Article  PubMed  CAS  Google Scholar 

  38. Csankovszki G, McDonel P, Meyer BJ: Recruitment and spreading of the C. elegans dosage compensation complex along X chromosomes. Science. 2004, 303 (5661): 1182-1185. 10.1126/science.1092938.

    Article  PubMed  CAS  Google Scholar 

  39. Dawes HE, Berlin DS, Lapidus DM, Nusbaum C, Davis TL, Meyer BJ: Dosage compensation proteins targeted to X chromosomes by a determinant of hermaphrodite fate. Science. 1999, 284 (5421): 1800-1804. 10.1126/science.284.5421.1800.

    Article  PubMed  CAS  Google Scholar 

  40. Lieb JD, de Solorzano CO, Rodriguez EG, Jones A, Angelo M, Lockett S, Meyer BJ: The Caenorhabditis elegans dosage compensation machinery is recruited to X chromosome DNA attached to an autosome. Genetics. 2000, 156 (4): 1603-1621.

    PubMed  CAS  PubMed Central  Google Scholar 

  41. Chu DS, Dawes HE, Lieb JD, Chan RC, Kuo AF, Meyer BJ: A molecular link between gene-specific and chromosome-wide transcriptional repression. Genes Dev. 2002, 16 (7): 796-805. 10.1101/gad.972702.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  42. Yonker SA, Meyer BJ: Recruitment of C. elegans dosage compensation proteins for gene-specific versus chromosome-wide repression. Development. 2003, 130 (26): 6519-6532. 10.1242/dev.00886.

    Article  PubMed  CAS  Google Scholar 

  43. Kaltenbach L, Horner MA, Rothman JH, Mango SE: The TBP-like factor CeTLF is required to activate RNA polymerase II transcription during C. elegans embryogenesis. Mol Cell. 2000, 6 (3): 705-713. 10.1016/S1097-2765(00)00068-X.

    Article  PubMed  CAS  Google Scholar 

  44. Brenner S: The genetics of Caenorhabditis elegans. Genetics. 1974, 77 (1): 71-94.

    PubMed  CAS  PubMed Central  Google Scholar 

  45. Horvitz HR, Brenner S, Hodgkin J, Herman RK: A uniform genetic nomenclature for the nematode Caenorhabditis elegans. Mol Gen Genet. 1979, 175 (2): 129-133. 10.1007/BF00425528.

    Article  PubMed  CAS  Google Scholar 

  46. Fire A: Integrative transformation of Caenorhabditis elegans. Embo J. 1986, 5 (10): 2673-2680.

    PubMed  CAS  PubMed Central  Google Scholar 

  47. Mello C, Fire A: DNA transformation. Methods Cell Biol. 1995, 48: 451-482.

    Article  PubMed  CAS  Google Scholar 

  48. Perry MD, Li W, Trent C, Robertson B, Fire A, Hageman JM, Wood WB: Molecular characterization of the her-1 gene suggests a direct role in cell signaling during Caenorhabditis elegans sex determination. Genes Dev. 1993, 7 (2): 216-228.

    Article  PubMed  CAS  Google Scholar 

  49. Frank DJ, Roth MB: ncl-1 is required for the regulation of cell size and ribosomal RNA synthesis in Caenorhabditis elegans. J Cell Biol. 1998, 140 (6): 1321-1329. 10.1083/jcb.140.6.1321.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Acknowledgements

We greatly thank Andrew Belmont for the fusion protein GFP-LacI and lacO repeat constructs as well for invaluable help developing this system, and Linda Huang for suggesting its use in mosaic analysis. We also thank Barbara Meyer for the dpy-30 promoter, Shahla Gharib for help with transgene integration, members of our laboratory for discussions and encouragement, and anonymous reviewers for helpful suggestions. The Caenorhabditis Genetic Center provided some strains. This work was supported USPHS (grant HD23690 to PWS) and by the Howard Hughes Medical Institute, with which P.W.S. is an Investigator. A.S.G-S. was a Howard Hughes Medical Institute Graduate Fellow.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul W Sternberg.

Additional information

Authors' contributions

AG-S designed and executed all the experiments. AG-S and PWS analyzed the data and wrote the paper.

Authors’ original submitted files for images

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Gonzalez-Serricchio, A.S., Sternberg, P.W. Visualization of C. elegans transgenic arrays by GFP. BMC Genet 7, 36 (2006). https://doi.org/10.1186/1471-2156-7-36

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/1471-2156-7-36

Keywords